Related Experiment Video
Updated: Jun 29, 2025
09:02
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.5K
Revolutionizing Neurocare: Biomimetic Nanodelivery Via Cell Membranes
Jun Liao1, Lidong Gong1, Qingqiang Xu2
1Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
Advanced Materials (Deerfield Beach, Fla.)
|April 7, 2024
Summary
Biomimetic nanodelivery systems, using cell membranes, offer a novel way to bypass the blood-brain barrier (BBB) for treating brain disorders. These advanced carriers enhance drug delivery, promising new neurocare strategies.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Neuroscience
Background:
- The blood-brain barrier (BBB) restricts conventional drug delivery to the brain, complicating treatment for neurological disorders.
- Developing effective therapies for brain diseases is hindered by the BBB's protective nature.
Purpose of the Study:
- To review biomimetic nanodelivery systems for overcoming BBB limitations.
- To explore cell membrane-based nanocarriers for enhanced brain drug delivery.
Main Methods:
- Review of literature on biomimetic nanocarriers (e.g., nanoghosts, membrane-coated nanoparticles).
- Examination of fabrication technologies for cell membrane-encapsulated nanoparticles.
- Comparison of biomimetic systems with traditional delivery methods.
Main Results:
- Biomimetic nanocarriers mimic native cells to improve drug penetration across the BBB.
- Various cell membranes (stem cell, tumor cell, erythrocyte) offer unique advantages for nanocarrier design.
- These systems enable targeted delivery of diverse therapeutics (small molecules, proteins).
Conclusions:
- Biomimetic nanodelivery systems represent a promising strategy for treating brain disorders.
- They offer targeted, sustained, and minimally invasive therapeutic options.
- Clinical translation holds transformative potential for intractable neurological diseases.
